
Overview
Background
Professor Craig Munns is the Mayne Professor of Paediatrics and Director of the Child Health Research Centre, The University of Queensland. Professor Munns is also a Senior Medical Officer in Paediatric Endocrinology and Diabetes at Queensland Children’s Hospital. He graduated from The University of Queensland, before training in paediatrics and endocrinology at The Royal Children’s Hospital, Brisbane. Professor Munns completed his PhD in paediatric growth disorders through UQ. He then undertook a post-doctoral fellowship in paediatric genetic bone disorders at The Shriners Hospital for Children, Montreal, Canada. From 2004 to 2021, Prof Munns was Senior Staff Specialist in Genetic and Metabolic Bone Disorders and Paediatric Endocrinologist at The Children’s Hospital at Westmead, Sydney. He also undertook roles as Clinical Program Director, Division of Diagnostic Services and Clinical Trials Lead at Kids Research. As Clinical Trials Lead his focus was on developing a research-intensive health system and introducing advanced therapeutics.
Professor Munns is an international expert in paediatric musculoskeletal disorders. His primary clinical and research interests are in diagnosis and management of primary and secondary bone disorders, including osteogenesis imperfecta, hypophosphataemic rickets, disuse osteoporosis and nutritional rickets. He has undertaken a wide range of investigator initiated and sponsored clinical trials, authored international consensus documents and has supervised numerous PhD and Masters students. Prof Munns is actively involved in national and international scientific societies. He was treasurer of Asia Pacific Paediatric Endocrine Society, is the inaugural treasurer of the International Society of Children’s Bone Health and has chaired the program organising committees Australasian Paediatric Endocrine Group, Australian and New Zealand Bone and Mineral Society and International Conference of Children’s Bone Health.
Availability
- Professor Craig Munns is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor of Faculty of Medicine, The University of Queensland
- Doctor of Philosophy of Paediatrics and Reproductive Medicine, The University of Queensland
- Fellow, Royal Australasian College of Physicians, Royal Australasian College of Physicians
Research interests
-
Paediatric Musculoskeletal Disorders
Primary and secondary osteoporosis; Genetic rickets (X-linked hypophosphataemia); Nutritional rickets; Focal bone tumours (Giant cell granuloma, Aneurismal bone cysts); Early detection of disease; Bone density assessment
-
Clinical Trials
Investigator initiated; Pharmaceutical sponsored; Gene therapy
Research impacts
Professor Munns has developed international consensus guidelines on the prevention and treatment of nutritional rickets. These guidelines have the potential to irradicate this potentially devastating, fully preventable childhood disorder. He has also developed numerous clinical guidelines for the management of paediatric bone disorders such as osteoporosis, X-linked hypophosphataemia, giant cell granuloma and aneurismal bone cysts.
Works
Search Professor Craig Munns’s works on UQ eSpace
2023
Journal Article
Management of RANKL-mediated disorders with denosumab in children and adolescents: a global expert guidance document
Vanderniet, Joel A., Szymczuk, Vivian, Högler, Wolfgang, Beck-Nielsen, Signe S., Uday, Suma, Merchant, Nadia, Crane, Janet L., Ward, Leanne M., Boyce, Alison M. and Munns, Craig F. (2023). Management of RANKL-mediated disorders with denosumab in children and adolescents: a global expert guidance document. The Journal of Clinical Endocrinology and Metabolism, 109 (5), 1371-1382. doi: 10.1210/clinem/dgad657
2023
Journal Article
Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial
Pittet, Laure F., Moore, Cecilia L., McDonald, Ellie, Barry, Simone, Bonten, Marc, Campbell, John, Croda, Julio, Dalcolmo, Margareth, Davidson, Andrew, Douglas, Mark W., Gardiner, Kaya, Gwee, Amanda, Jardim, Bruno, Lacerda, Marcus V.G., Lucas, Michaela, Lynn, David J., Manning, Laurens, de Oliveira, Roberto D., Perrett, Kirsten P., Prat-Aymerich, Cristina, Richmond, Peter C., Rocha, Jorge L., Rodriguez-Baño, Jesus, Warris, Adilia, Wood, Nicholas J., Messina, Nicole L., Curtis, Nigel, Jamieson, Tenaya, Messina, Nicole ... Venton, Tamsin (2023). Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial. eClinicalMedicine, 64 102203, 102203. doi: 10.1016/j.eclinm.2023.102203
2023
Journal Article
Prevalence and characteristics of paediatric X-linked hypophosphataemia in Australia and New Zealand: Results from the Australian and the New Zealand Paediatric Surveillance Units survey
Sandy, Jessica L., Nunez, Carlos, Wheeler, Benjamin J., Jefferies, Craig, Morris, Anne, Siafarikas, Aris, Rodda, Christine P., Simm, Peter, Biggin, Andrew, Aum, Sonya, Elliot, Elizabeth J. and Munns, Craig F. (2023). Prevalence and characteristics of paediatric X-linked hypophosphataemia in Australia and New Zealand: Results from the Australian and the New Zealand Paediatric Surveillance Units survey. Bone, 173 116791, 116791. doi: 10.1016/j.bone.2023.116791
2023
Journal Article
Vitamin D testing in children and adolescents in Victoria, Australia: are testing practices in line with global recommendations?
Zurynski, Yvonne, Munns, Craig Frank, Sezgin, Gorkem, Imai, Chisato and Georgiou, Andrew (2023). Vitamin D testing in children and adolescents in Victoria, Australia: are testing practices in line with global recommendations?. Archives of Disease in Childhood, 108 (9), 742-747. doi: 10.1136/archdischild-2022-325000
2023
Journal Article
Serum 1,25-dihydroxyvitamin D levels in the diagnosis and pathogenesis of nutritional rickets – a multivariable re-analysis of a case-control study
Fischer, Philip R., Sempos, Christopher T., Pettifor, John M., Fraser, David R., Munns, Craig F., Durazo-Arvizu, Ramon A. and Thacher, Tom D. (2023). Serum 1,25-dihydroxyvitamin D levels in the diagnosis and pathogenesis of nutritional rickets – a multivariable re-analysis of a case-control study. The American Journal of Clinical Nutrition, 117 (5), 998-1004. doi: 10.1016/j.ajcnut.2023.02.011
2023
Journal Article
Randomized trial of BCG vaccine to protect against Covid-19 in health care workers
Pittet, Laure F., Messina, Nicole L., Orsini, Francesca, Moore, Cecilia L., Abruzzo, Veronica, Barry, Simone, Bonnici, Rhian, Bonten, Marc, Campbell, John, Croda, Julio, Dalcolmo, Margareth, Gardiner, Kaya, Gell, Grace, Germano, Susie, Gomes-Silva, Adriano, Goodall, Casey, Gwee, Amanda, Jamieson, Tenaya, Jardim, Bruno, Kollmann, Tobias R., Lacerda, Marcus V.G., Lee, Katherine J., Lucas, Michaela, Lynn, David J., Manning, Laurens, Marshall, Helen S., McDonald, Ellie, Munns, Craig F., Nicholson, Suellen ... Curtis, Nigel (2023). Randomized trial of BCG vaccine to protect against Covid-19 in health care workers. New England Journal of Medicine, 388 (17), 1582-1596. doi: 10.1056/nejmoa2212616
2023
Journal Article
Burosumab versus phosphate/active vitamin D in pediatric x-linked hypophosphatemia: a sub-group analysis by dose level
Imel, Erik A, Glorieux, Francis H, Whyte, Michael P, Portale, Anthony A, Munns, Craig F, Nilsson, Ola, Simmons, Jill H, Padidela, Raja, Namba, Noriyuki, Cheong, Hae Il, Pitukcheewanont, Pisit, Sochett, Etienne, Högler, Wolfgang, Muroya, Koji, Tanaka, Hiroyuki, Gottesman, Gary S, Biggin, Andrew, Perwad, Farzana, Chen, Angel, Roberts, Mary Scott and Ward, Leanne M (2023). Burosumab versus phosphate/active vitamin D in pediatric x-linked hypophosphatemia: a sub-group analysis by dose level. The Journal of Clinical Endocrinology and Metabolism, 108 (11), 2990-2998. doi: 10.1210/clinem/dgad230
2023
Journal Article
Asia-Pacific consensus recommendations on x-linked hypophosphatemia: diagnosis, multidisciplinary management, and transition from pediatric to adult care
Munns, Craig F, Yoo, Han-Wook, Jalaludin, Muhammad Yazid, Vasanwala, Rashida, Chandran, Manju, Rhee, Yumie, But, Wai Man, Kong, Alice Pik-Shan, Su, Pen-Hua, Numbenjapon, Nawaporn, Namba, Noriyuki, Imanishi, Yasuo, Clifton-Bligh, Roderick J, Luo, Xiaoping and Xia, Weibo (2023). Asia-Pacific consensus recommendations on x-linked hypophosphatemia: diagnosis, multidisciplinary management, and transition from pediatric to adult care. JBMR Plus, 7 (6) e10744, e10744. doi: 10.1002/jbm4.10744
2023
Journal Article
Surgical management and denosumab for aneurysmal bone cysts of the spine in an Australian tertiary paediatric centre
Vanderniet, Joel A., Tsinas, Dionysios, Wall, Christie-Lee, Girgis, Christian M., London, Kevin, Keane, Corinne, Briody, Julie, Hibbert, Sally, Poon, Myra, Padhye, Bhavna, Biggin, Andrew, Dalla-Pozza, Luciano, Gray, Randolph J. and Munns, Craig F. (2023). Surgical management and denosumab for aneurysmal bone cysts of the spine in an Australian tertiary paediatric centre. Calcified Tissue International, 112 (5), 592-602. doi: 10.1007/s00223-023-01068-1
2023
Journal Article
Targeted postnatal knockout of Sclerostin using a bone-targeted adeno-associated viral vector increases bone anabolism and decreases canalicular density
O'Donohue, Alexandra K., Xiao, Ya, Lee, Lucinda R., Schofield, Timothy, Cheng, Tegan L., Munns, Craig F., Baldock, Paul A. and Schindeler, Aaron (2023). Targeted postnatal knockout of Sclerostin using a bone-targeted adeno-associated viral vector increases bone anabolism and decreases canalicular density. Bone, 167 116636, 1-9. doi: 10.1016/j.bone.2022.116636
2023
Journal Article
Craniosynostosis in patients with x‐linked hypophosphataemia: a review
Munns, Craig F, Maguire, Edward P, Williams, Angela, Wood, Sue and Biggin, Andrew (2023). Craniosynostosis in patients with x‐linked hypophosphataemia: a review. JBMR Plus, 7 (5) e10728, e10728. doi: 10.1002/jbm4.10728
2023
Journal Article
Expanding the phenotype of Bruck syndrome: severe limb deformity, arthrogryposis, congenital cardiac disease and pulmonary hemorrhage
Sandy, Jessica L., Perez, Darazel, Goh, Shuxiang, Forsey, Jonathan, Rajagopalan, Sulekha, Trivedi, Amit and Munns, Craig F. (2023). Expanding the phenotype of Bruck syndrome: severe limb deformity, arthrogryposis, congenital cardiac disease and pulmonary hemorrhage. American Journal of Medical Genetics, Part A, 191 (1), 265-270. doi: 10.1002/ajmg.a.63007
2022
Journal Article
Feasibility, safety, and efficacy of 12-week side-to-side vibration therapy in children and adolescents with congenital myopathy in New Zealand
Adaikina, Alena, Derraik, José G B, Power, Lisa C, Grady, Gina O, Munns, Craig F, Hofman, Paul L and Gusso, Silmara (2022). Feasibility, safety, and efficacy of 12-week side-to-side vibration therapy in children and adolescents with congenital myopathy in New Zealand. Neuromuscular Disorders, 32 (10), 820-828. doi: 10.1016/j.nmd.2022.07.398
2022
Journal Article
Childhood type 1 diabetes is associated with abnormal bone development
Vora, Komal Ashokbhai, Munns, Craig F., Donaghue, Kim C., Craig, Maria E., Briody, Julie and Benitez-Aguirre, Paul (2022). Childhood type 1 diabetes is associated with abnormal bone development. Pediatric Diabetes, 23 (6), 773-782. doi: 10.1111/pedi.13367
2022
Conference Publication
Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab versus conventional therapy in children with X-linked hypophosphatemia: results from the 24-week treatment extension period
Padidela, Raja, Whyte, Michael P., Glorieux, Francis H., Munns, Craig F., Ward, Leanne M., Nilsson, Ola, Portale, Anthony A., Simmons, Jill H., Namba, Noriyuki, Cheong, Hae Il, Pitukcheewanont, Pisit, Sochett, Etienne, Hoegler, Wolfgang, Muroya, Koji, Gottesman, Gary S., Biggin, Andrew, Perwad, Farzana, Williams, Angela, Nixon, Annabel, Sun, Wei, Chen, Angel, Skrinar, Alison and Imel, Erik A. (2022). Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab versus conventional therapy in children with X-linked hypophosphatemia: results from the 24-week treatment extension period. BASEL: KARGER.
2022
Journal Article
Effect of burosumab compared with conventional therapy on younger vs older children with x-linked hypophosphatemia
Ward, Leanne M., Glorieux, Francis H., Whyte, Michael P., Munns, Craig F., Portale, Anthony A., Högler, Wolfgang, Simmons, Jill H., Gottesman, Gary S., Padidela, Raja, Namba, Noriyuki, Cheong, Hae Il, Nilsson, Ola, Mao, Meng, Chen, Angel, Skrinar, Alison, Roberts, Mary Scott and Imel, Erik A. (2022). Effect of burosumab compared with conventional therapy on younger vs older children with x-linked hypophosphatemia. The Journal of Clinical Endocrinology and Metabolism, 107 (8), e3241-e3253. doi: 10.1210/clinem/dgac296
2022
Journal Article
Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre
Vanderniet, Joel A., Wall, Christie-Lee, Mullins, Anna, London, Kevin, Lim, Lydia, Hibbert, Sally, Briody, Julie, Padhye, Bhavna, Poon, Myra, Biggin, Andrew, Dalla-Pozza, Luciano and Munns, Craig F. (2022). Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre. Bone, 159 116395, 1-9. doi: 10.1016/j.bone.2022.116395
2022
Journal Article
Combination treatment with growth hormone and zoledronic acid in a mouse model of Osteogenesis imperfecta
Lee, Lucinda R., Holman, Aimee E., Li, Xiaoying, Vasiljevski, Emily R., O'Donohue, Alexandra K., Cheng, Tegan L., Little, David G., Schindeler, Aaron, Biggin, Andrew and Munns, Craig F. (2022). Combination treatment with growth hormone and zoledronic acid in a mouse model of Osteogenesis imperfecta. Bone, 159 116378, 1-12. doi: 10.1016/j.bone.2022.116378
2022
Journal Article
Clinical practice guidelines for paediatric X-linked hypophosphataemia in the era of burosumab
Sandy, Jessica L., Simm, Peter J., Biggin, Andrew, Rodda, Christine P., Wall, Christie-Lee, Siafarikas, Aris and Munns, Craig F. (2022). Clinical practice guidelines for paediatric X-linked hypophosphataemia in the era of burosumab. Journal of Paediatrics and Child Health, 58 (5), 762-768. doi: 10.1111/jpc.15976
2022
Journal Article
Clinical and radiologic response of central giant cell granuloma to denosumab: A 6-year prospective observational study
Rhou, Yoon Ji Jina, Wang, Che-Jen, Nguyen, Minh, Vanderniet, Joel A., Munns, Craig F., Coleman, Hedley, Kim, James, Holmes-Walker, Deborah Jane, Lim, Lydia and Girgis, Christian M. (2022). Clinical and radiologic response of central giant cell granuloma to denosumab: A 6-year prospective observational study. Calcified Tissue International, 110 (4), 464-474. doi: 10.1007/s00223-021-00935-z
Funding
Current funding
Supervision
Availability
- Professor Craig Munns is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Tele-Dialysis in community settings: Is it feasible, safe and effective?
Principal Advisor
-
Doctor Philosophy
Urinary stem cells for diagnosis and characterisation of primary bone disorders
Principal Advisor
Other advisors: Professor Di Yu
-
Doctor Philosophy
Food Allergy Diagnosis and Management in Late Adolescence
Associate Advisor
Other advisors: Associate Professor Jennifer Koplin
Media
Enquiries
Contact Professor Craig Munns directly for media enquiries about:
- Paediatric Bone
- Rickets
- Vitamin D
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: